Lumen in the News: Beyond the lung: treating the GI symptoms of Covid-19 https://t.co/wV1VpDDQYV via @PharmaTechFocus
Pleased to announced up to $14.5M @CARB_X funded project and publication detailing our novel spirulina platform app… https://t.co/s50wROyaHm
We've been recognized by @IAmBiotech as a finalist in Buzz of BIO. PLEASE VOTE here: https://t.co/unz0MoV7hs for Lu… https://t.co/c52R85I6T5
Q&A with Lumen CEO @Finrow and @jimseattle: using spirulina to manufacture #Covid19 antibodies https://t.co/vJdaP5K6Vu via @PharmaTechFocus
Lumen is pleased to partner with @UWmedicine and @ClevelandClinic scientists to create novel nanobodies for kidney… https://t.co/zpQmL7Xarz
Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors $ATHA https://t.co/Mr6VccX21K https://t.co/Ix5Di0wj6J
Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic… https://t.co/fPzzENGtrl
Lumen Bioscience Announces Appointment of Mike Spigarelli as Chief Medical Officer https://t.co/lB0EFBTbL0 https://t.co/8FpzzvHIzk
Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs… https://t.co/BUmLTOWBeE
We're seeking a data scientist to help us collect and integrate data from all of the phases of bioindustrial production.